Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study.
Rosoff DB., Bell AS., Mavromatis LA., Hamandi A., Park L., Jung J., Wagner J., Pacher P., Ray D., Davey Smith G., Lohoff FW.